Genetic Markers Predict Primary Nonresponse and Durable Response to Anti–Tumor Necrosis Factor Therapy in Ulcerative Colitis

BACKGROUND: Despite a high nonresponse rate, predictors of response to anti–tumor necrosis factor (anti-TNF) therapy in ulcerative colitis (UC) remain limited. We aim to determine clinical and genetic predictors of primary nonresponse (PNR) and durable response (DR) to anti-TNF therapy in a large pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Inflamm Bowel Dis
Autors principals: Burke, Kristin E, Khalili, Hamed, Garber, John J, Haritunians, Talin, McGovern, Dermot P B, Xavier, Ramnik J, Ananthakrishnan, Ashwin N
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Original Clinical Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6128143/
https://ncbi.nlm.nih.gov/pubmed/29718226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy083
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars